Results 11 to 20 of about 2,397 (207)

Real‐World Experience with a Human Fibrinogen Concentrate: Clinical Data from Adult and Pediatric Patients Requiring Fibrinogen for Bleeding Control and Prevention

The Journal of Clinical Pharmacology, Volume 63, Issue 11, Page 1186-1196, November 2023., 2023
Abstract Human fibrinogen concentrate (Fibryga) received temporary approval for fibrinogen replacement therapy in France (2017), with subsequent full approval for congenital and acquired hypofibrinogenemia. We evaluated real‐world use for on‐demand treatment of bleeding and prophylaxis to enhance our knowledge on fibrinogen concentrate as an option for
Francois Stéphan, Loriane Gutermann, Stéphanie Bourget, Sarah Djabarouti, Johanna Berdugo, Yann Fardini, Pierre Clerson, Guillaume Hébert, Chafké Belmokhtar   +8 more
wiley   +1 more source

Decompressive surgery in cerebral venous sinus thrombosis due to vaccine‐induced immune thrombotic thrombocytopenia

European Journal of Neurology, Volume 30, Issue 5, Page 1335-1345, May 2023., 2023
Abstract Background and purpose Cerebral venous sinus thrombosis due to vaccine‐induced immune thrombotic thrombocytopenia (CVST‐VITT) is an adverse drug reaction occurring after severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) vaccination.
Katarzyna Krzywicka, Diana Aguiar de Sousa, Charlotte Cordonnier, Felix J. Bode, Thalia S. Field, Dominik Michalski, Johann Pelz, Mona Skjelland, Markus Wiedmann, Julian Zimmermann, Matthias Wittstock, Bruno Zanotti, Alfonso Ciccone, Monica Bandettini di Poggio, Afshin Borhani‐Haghighi, Sophie Chatterton, Avinash Aujayeb, Annemie Devroye, Vanessa Dizonno, Thomas Geeraerts, Fabrizio Giammello, Albrecht Günther, Nasli R. Ichaporia, Timothy Kleinig, Espen S. Kristoffersen, Robin Lemmens, Emmanuel De Maistre, Zahra Mirzaasgari, Jean‐Francois Payen, Jukka Putaala, Marco Petruzzellis, Nicolas Raposo, Elyar Sadeghi‐Hokmabadi, Silvia Schoenenberger, Meenakshisundaram Umaiorubahan, Padmavathy N Sylaja, Anita van de Munckhof, Mayte Sánchez van Kammen, Erik Lindgren, Katarina Jood, Adrian Scutelnic, Mirjam R. Heldner, Sven Poli, Marieke J. H. A. Kruip, Antonio Arauz, Adriana B. Conforto, Sanjith Aaron, Saskia Middeldorp, Turgut Tatlisumak, Marcel Arnold, Jonathan M. Coutinho, José M. Ferro, Cerebral Venous Sinus Thrombosis with Thrombocytopenia Syndrome Study Group   +52 more
wiley   +1 more source

Neurological symptoms and complications in predominantly hospitalized COVID‐19 patients: Results of the European multinational Lean European Open Survey on SARS‐Infected Patients (LEOSS)

European Journal of Neurology, Volume 28, Issue 12, Page 3925-3937, December 2021., 2021
We retrospectively analyzed data from 6537 predominantly hospitalized COVID‐19 patients registered in the European multinational Lean European Open Survey on SARS‐Infected Patients (LEOSS) registry between January 2020 and February 2021. Common neurological symptoms were excessive tiredness (28.0%), headache (18.5%), nausea/emesis (16.6%), muscular ...
Nina N. Kleineberg, Samuel Knauss, Eileen Gülke, Hans O. Pinnschmidt, Carolin E. M. Jakob, Paul Lingor, Kerstin Hellwig, Achim Berthele, Günter Höglinger, Gereon R. Fink, Matthias Endres, Christian Gerloff, Christine Klein, Melanie Stecher, Annika Y. Classen, Siegbert Rieg, Stefan Borgmann, Frank Hanses, Maria M. Rüthrich, Martin Hower, Lukas Tometten, Martina Haselberger, Christiane Piepel, Uta Merle, Sebastian Dolff, Christian Degenhardt, Björn‐Erik O. Jensen, Maria J. G. T. Vehreschild, Johanna Erber, Christiana Franke, Clemens Warnke, the LEOSS Study Group   +31 more
wiley   +1 more source

Umbilical cord mesenchymal stem cells for COVID‐19 acute respiratory distress syndrome: A double‐blind, phase 1/2a, randomized controlled trial

STEM CELLS Translational Medicine, Volume 10, Issue 5, Page 660-673, May 2021., 2021
Abstract Acute respiratory distress syndrome (ARDS) in COVID‐19 is associated with high mortality. Mesenchymal stem cells are known to exert immunomodulatory and anti‐inflammatory effects and could yield beneficial effects in COVID‐19 ARDS. The objective of this study was to determine safety and explore efficacy of umbilical cord mesenchymal stem cell (
Giacomo Lanzoni, Elina Linetsky, Diego Correa, Shari Messinger Cayetano, Roger A. Alvarez, Dimitrios Kouroupis, Ana Alvarez Gil, Raffaella Poggioli, Phillip Ruiz, Antonio C. Marttos, Khemraj Hirani, Crystal A. Bell, Halina Kusack, Lisa Rafkin, David Baidal, Andrew Pastewski, Kunal Gawri, Clarissa Leñero, Alejandro M. A. Mantero, Sarah W. Metalonis, Xiaojing Wang, Luis Roque, Burlett Masters, Norma S. Kenyon, Enrique Ginzburg, Xiumin Xu, Jianming Tan, Arnold I. Caplan, Marilyn K. Glassberg, Rodolfo Alejandro, Camillo Ricordi   +30 more
wiley   +1 more source

Recovery from Liver Failure and Fibrosis in a Rat Portacaval Anastomosis Model after Neurointermediate Pituitary Lobectomy

Journal of Immunology Research, Volume 2021, Issue 1, 2021., 2021
Liver diseases, including cirrhosis, viral hepatitis, and hepatocellular carcinoma, account for approximately two million annual deaths worldwide. They place a huge burden on the global healthcare systems, compelling researchers to find effective treatment for liver fibrosis‐cirrhosis.
Martín Muñoz-Ortega, Noé Macías-Segura, Javier Ventura-Juárez, Manuel Enrique Ávila-Blanco, Leonardo D. Ponce-Damian, Daniel González-Blas, Esperanza Sánchez-Alemán, Andrés Quintanar-Stephano, Charles Elias Assmann   +8 more
wiley   +1 more source

HIPERSENSIBILIDADE RETARDADA A HEPARINA DE BAIXO PESO MOLECULAR – QUE ALTERNATIVA À ANTICOAGULAÇÃO?

Revista da Sociedade Portuguesa de Dermatologia e Venereologia, 2013
Um doente de 75 anos de idade, obeso, realizou terapêutica anticoagulante por trombose venosa profunda (TVP) do membro inferior: heparina clássica endovenosa durante 3 dias e dalteparina subcutânea durante 10 dias.
Ana Brinca, Felicidade Santiago, Leonor Ramos, Óscar Tellechea, Margarida Gonçalo   +4 more
doaj   +1 more source

Enfermedad tromboembólica en Obstetricia y Ginecología

Revista Colombiana de Obstetricia y Ginecología, 1997
Se realiza una revisión que comprende: los mecanismos de la hemostasia, los factores predisponentes de la enfermedad tromboembólica, los métodos diagnósticos, la profilaxis y el tratamiento de la misma.
Federación Colombiana de Obstetricia y Ginecología
doaj   +1 more source

Comparação entre heparina de baixo peso molecular e heparina não fraccionada intravenosa no tratamento da embolia pulmonar — Uma meta-análise de estudos controlados randomizados

Revista Portuguesa de Pneumologia, 2004
RESUMO: O tratamento da embolia pulmonar aguda (EPA) com heparina de baixo peso molecular não é consensual. Muitos clínicos continuam a utilizar a heparina não fraccionada por considerarem que o EPA apresenta maior risco do que a trombose venosa ...
Daniel Quinlan, Andrew Mcquillan, John Eikel Boom Ann   +2 more
doaj   +1 more source

Suitability of the use of low-molecular-weight heparins in the prevention of venous thromboembolism [PDF]

, 2008
Objetivo: Conocer la prevalencia de prescripción de heparinas de bajo peso molecular (HBPM) en la profilaxis de la enfermedad tromboembólica venosa en un hospital general, así como la adecuación a las recomendaciones de las guías de práctica clínica.
Ageno, Alonso Ortiz del Río, Anderson, Aouizerate, Bergmann, Bratzler, Callaert, Chopard, Deheinzelin, Enoxacan study group, Estado actual de la profilaxis primaria de la enfermedad tromboembólica venosa, Fernández, Garrido, Geerts, Geerts, Grupo de estudio del tromboembolismo de la Sociedad Española de Cirugía Ortopédica y Traumatología, I. Chaparro Moreno, J. Herrera Carranza, J.A. de la Rosa Báez, L.C. Fernández Lisón, Lacherade, M. Aguayo Canela, M. Ynfante Ferrus, M.T. Garrido Martínez, Pini, Rahim, Samama, Silverstein, Sociedad Andaluza de Farmacéuticos de Hospital, The National Institute for Health and Clinical Excellence (NICE), Valles   +30 more
core   +1 more source

Inhibidores directos del Factor Xa para la prevención del tromboembolismo en pacientes sometidos a reemplazo total de cadera o de rodilla. Protocolo de una revisión sistemática

ARS Medica, 2012
Los reemplazos articulares de cadera y la rodilla se encuentran entre los procedimientos quirúrgicos más comunes en América del Norte y Europa y están aumentando en frecuencia. La enfermedad tromboembólica es la complicación médica más frecuente en este
Ignacio Neumann, Gabriel Rada, Juan Carlos Claro, Alonso Carrasco, Kristian Thorlund, Elie A Akl, Shannon Bates, Gordon H Guyatt   +7 more
doaj   +1 more source